Pharmaceutical Technology

DECEMBER 4, 2023

GC Biopharma has concluded the construction activities at an mRNA manufacturing plant at its vaccine production site in South Korea.

Biopharma 52

Biopharma Manufacturing 52

Fierce Pharma

MAY 1, 2024

biopharma companies rely on Chinese contractors to provide lab research and drug manufacturing services. It’s no secret that U.S. Facing a push for China-U.S. decoupling from Washington, the industry trade group BIO now wants to quantify the U.S.’s s dependence on Chinese CDMOs through a survey.

Biopharma 253

Biopharma Manufacturing 253

European Pharmaceutical Review

MAY 20, 2024

billion antibody drug conjugate (ADC) manufacturing facility in Singapore is set to increase global supply of AstraZeneca’s ADC portfolio. All steps of the manufacturing process at a commercial scale will be incorporated. billion ADC manufacturing facility in Singapore. The post AstraZeneca announces $1.5b

Manufacturing 70

Manufacturing Biopharma Pharmaceutical Pharma 70

Fierce Pharma

MAY 10, 2024

While some biopharma contract manufacturers have been able to weather a tough business environment in recent months, many others continue to struggle against financing headwinds affecting the great | AGC Biologics, which employs more than 2,500 workers worldwide, has “had to reduce positions at our Seattle and Colorado sites and global functional areas,” (..)

Biopharma 257

Biopharma Manufacturing 257

Fierce Pharma

MARCH 15, 2024

Over the years, Singapore has attracted a suite of biopharma majors, and Novartis is no exception. The project will introduce digitalization and automation at the site in a bid to boost manufacturing productivity and to help upskill the company’s workforce.

Biopharma 302

Biopharma Manufacturing 302

PharmaTech

JANUARY 10, 2024

Franco Negron, CEO, Simtra BioPharma Solutions, discusses the company's expertise in supporting the development and manufacture of sterile injectables, its integrated approach to project management, and his expectations regarding the company's future in the industry.

Biopharma 59

Biopharma Manufacturing Management 59

Fierce Pharma

JANUARY 4, 2024

Even after the heady highs of the COVID-19 era, the contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields. Even after the heady highs of the COVID era, the CDMO realm remains one of biopharma's buzziest fields.

Biopharma 274

Biopharma Manufacturing 274

European Pharmaceutical Review

JUNE 7, 2023

The global biopharma industry’s resilience has decreased since 2021, a report by Cytiva has found. Using feedback from 1250 pharma and biopharma executives in 22 countries, the research sought to find out how has the biopharma industry has evolved over the past two years and what areas the industry should seek to improve.

Biopharma 76

Biopharma Government Manufacturing Pharma 76

European Pharmaceutical Review

APRIL 17, 2023

A report on automation in the biopharma industr y has shown that the market is projected to grow at a compound annual growth rate (CAGR) of 5.7 Factors impacting the automation in the biopharma industry market The report found that 75 percent of pharmaceutical organisations want to use automated solutions more frequently.

Biopharma 90

Biopharma Manufacturing Pharmaceutical products Marketing 90

PharmaTech

MAY 25, 2024

The partnership aims to provide end-to-end development and manufacturing for biopharmaceutical drug substance and drug product.

Manufacturing 52

Manufacturing Biopharma 52

European Pharmaceutical Review

MARCH 20, 2024

Single-use filtration systems can help streamline processes and enhance efficiency of biopharma production. The post ebook: A practical guide to single-use filtration in biopharma appeared first on European Pharmaceutical Review. Interested to know more? Register your details now!

Biopharma 64

Biopharma Specialization Manufacturing Medical 64

European Pharmaceutical Review

FEBRUARY 16, 2024

Researchers have highlighted the potential of end-to-end continuous manufacture with column-free capture alternatives. they are a “prime” test option for continuous manufacturing. Since monoclonal antibodies (mAbs) represent the fastest growing biopharmaceutical market segment, according to Neves et al. Neves et al. Neves et al.

Manufacturing 77

Manufacturing Biopharma Pharmaceutical Marketing 77

PharmaTech

JANUARY 9, 2024

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals, highlights traits that a (bio)pharmaceutical company look for when identifying a CDMO to support drug development and manufacturing programs.

Manufacturing 52

Manufacturing Biopharma Pharmaceutical 52

European Pharmaceutical Review

APRIL 15, 2024

billion to expand the planned FUJIFILM Diosynth Biotechnologies manufacturing facility in Holly Springs, North Carolina, US. The expansion means identical large-scale production facilities can be built in US and Europe to support integration drug manufacturing production “regardless of location”, FUJIFILM explained.

Manufacturing 81

Manufacturing Biopharma Networking Pharmaceutical 81

Pharmaceutical Technology

MARCH 1, 2024

Simtra BioPharma has announced plans invest $250m for an expansion of its sterile fill/finish manufacturing site in Bloomington, Indiana, US.

Biopharma 52

Biopharma Manufacturing 52

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Marketing 59

PharmaTech

FEBRUARY 28, 2024

Manufacturing site. The company is investing more than $250 million into its Bloomington, Ind.

Manufacturing 59

Manufacturing Biopharma 59

European Pharmaceutical Review

JULY 7, 2023

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

Competition 84

Competition Biopharma Government Manufacturing 84

MedCity News

MAY 20, 2024

The Singapore manufacturing site will be AstraZeneca’s first facility capable of handling all steps of antibody drug conjugate production. Manufacturing Site for Global Production of ADC Cancer Drugs appeared first on MedCity News. AstraZeneca aims to open the facility in 2029. The post AstraZeneca Plans $1.5B

Manufacturing 104

Manufacturing Biopharma Pharma 104

European Pharmaceutical Review

SEPTEMBER 5, 2023

million to establish a Medicines Manufacturing Skills Centre of Excellence. Enhancing talent in pharmaceutical manufacturing “Talent and skills are fundamental to successful innovation and industry growth. The UK government is investing £5.5

Medicine 83

Medicine Manufacturing Biopharma Pharmaceutical manufacturing 83

European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The first is removal of the RDP extension for pan-EU launch within two years, instead requiring manufacturers to submit to local P&MA processes upon request by the member state.

Biopharma 82

Biopharma Pharmaceutical Medicine Manufacturing 82

PharmExec

SEPTEMBER 16, 2022

Administration launches national manufacturing initiative, with aim to reduce US reliance on biomedicine from China and other regions.

Manufacturing 98

Manufacturing Biopharma 98

European Pharmaceutical Review

SEPTEMBER 11, 2023

The Cell and Gene Therapy Catapult (CGT Catapult) is set to improve the process and efficiency of AAV manufacture for gene therapies as part of a two-year project alongside two other organisations. The new PAT project aims develop an automated gene therapy manufacturing platform. What will the PAT project involve?

Manufacturing 76

Manufacturing Biopharma Medicine Leads 76

MedCity News

MAY 10, 2024

By doing this, CybergenX is seeking to accelerate the potential of engineering biology in drug manufacturing. The post This Chip Seeks to Transform Drug Manufacturing by Learning More About Intracellular Dynamics appeared first on MedCity News.

Manufacturing 98

Manufacturing Engineering Biopharma 98

European Pharmaceutical Review

SEPTEMBER 4, 2023

The biopharma company will be required to seek prior approval before acquiring related products. Divest to invest: the new normal in biopharma? The post FTC order could ease biopharma competition appeared first on European Pharmaceutical Review. The FTC has settled on a proposed consent order with Amgen Inc.

Competition 81

Competition Biopharma Pharmaceutical Government 81

European Pharmaceutical Review

NOVEMBER 16, 2022

As the emphasis of new drug development gravitates towards new, ground-breaking therapies and vaccines, the requirements of manufacturing sites, equipment and processes need to be appropriate for this new environment. That is because of the relative expense of emerging therapies and the pressure on pricing for continuing product lines.

Manufacturing 111

Manufacturing Pharma Biopharma Management 111

MedCity News

NOVEMBER 14, 2022

These platforms need to replace traditional data management methods and workflows for biopharma companies and contract development and manufacturing organizations that seek competitive advantages. Cloud-based data management solutions help the industry meet its business and compliance challenges.

Biopharma 85

Biopharma Management Manufacturing Competition 85

European Pharmaceutical Review

AUGUST 22, 2023

According to UK Research and Innovation ( UKRI ), £13 million is set to fund medicine manufacturing in the UK, through a focus on innovation in intracellular drug delivery, digitalisation and automation and nucleic acid medicines. Seventeen new projects from the Innovate UK Transforming Medicine Manufacturing programme will benefit.

Medicine 86

Medicine Manufacturing Biopharma Competition 86

PharmaTech

JULY 2, 2022

Automation and digitalization work together in the digital plant.

Biopharma 119

Biopharma Manufacturing 119

PharmaTech

JANUARY 9, 2024

Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.

Manufacturing 52

Manufacturing Biopharma Pharma Sales 52

European Pharmaceutical Review

NOVEMBER 20, 2023

billion parenteral (injectable) manufacturing site in Alzey, Rhineland-Palatinate, Germany. This includes automation and high-speed manufacturing lines. With the planned additional manufacturing facility in Alzey, the company will operate a total of six manufacturing sites in Europe.

Manufacturing 83

Manufacturing Medicine Biopharma Engineering 83

European Pharmaceutical Review

JULY 17, 2023

A new three-year research programme led by researchers at Massachusetts Institute of Technology ( MIT ) is aiming to design the world’s first fully integrated, continuous mRNA manufacturing platform. However, continuous manufacturing enables a product to be made non-stop and avoids delays caused by pauses and transfers between batches.

Manufacturing 91

Manufacturing Food and Drug Administration Engineering Biopharma 91

European Pharmaceutical Review

AUGUST 22, 2022

However, the biopharma industries realised that traditional vaccine development and manufacturing techniques, which take around five to 10 years for initial development to large-scale distribution, 1 were inadequate to meet the growing demand for COVID-19 vaccines. Digital technologies for smart vaccine manufacturing.

Manufacturing 87

Manufacturing Biopharma Engineering Safety 87

Pharmaceutical Technology

AUGUST 28, 2023

GC Biopharma has signed a memorandum of understanding (MOU) with Eubiologics to jointly manufacture oral cholera vaccine, Euvichol.

Biopharma 52

Biopharma Manufacturing 52

Fierce Pharma

MAY 25, 2023

As drugmakers advance a wave of new cell and gene therapies, contract manufacturers have captured a larger share of the biopharma spotlight in recent years as they push to meet ever-increasing dema | As drugmakers advance a wave of new cell and gene therapies, contract manufacturers have captured a larger share of the biopharma spotlight in recent (..)

Biopharma 130

Biopharma Manufacturing 130

Fierce Pharma

JUNE 13, 2023

By: William Blake, Chief Technology Officer, Human-Based R&D | Danaher Life Sciences companies are ushering in a new era of engineering biology, partnering with biopharma leaders to deploy automation, AI and other engineering practices from early research through manufacturing.

Engineering 193

Engineering Biopharma Manufacturing 193

PharmaTech

JULY 26, 2023

In this episode of Drug Digest, Pharmaceutical Technology editors discuss what happens in the manufacturing space from a CDMO and a cell/gene therapy perspective.

Manufacturing 52

Manufacturing Biopharma Pharmaceutical 52